[Federal Register Volume 65, Number 76 (Wednesday, April 19, 2000)]
[Notices]
[Pages 20991-20992]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9714]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 99N-4202]


Agency Information Collection Activities; Announcement of OMB 
Approval; Application to Market a New Drug, Biologic, or an Antibiotic 
Drug for Human Use

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Application to Market a New Drug, 
Biologic, or an Antibiotic Drug for Human Use'' has been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 2, 2000 
(65 FR 4979), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An

[[Page 20992]]

agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number. OMB has now approved the information 
collection and has assigned OMB control number 0910-0338. The approval 
expires on March 31, 2003. A copy of the supporting statement for this 
information collection is available on the Internet at http://www.fda.gov/ohrms/dockets.

    Dated: April 12, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-9714 Filed 4-18-00; 8:45 am]
BILLING CODE 4160-01-F